Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis
Open accessThe DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Abstract
Neuromuscular junction assembly and plasticity during embryonic, postnatal, and adult life are tightly regulated by the continuous cross-talk among motor nerve endings, muscle fibers, and glial cells. Altered communications among these components is thought to be responsible for the physiological age-related changes at this synapse and possibly for its destruction in pathological states. Neuromuscular junction dismantling plays a crucial role in the onset of Amyotrophic Lateral Sclerosis (ALS). ALS is characterized by the degeneration and death of motor neurons leading to skeletal muscle denervation, atrophy and, most often, death of the patient within five years from diagnosis. ALS is a non-cell autonomous disease as, besides motor neuron degeneration, glial cells, and possibly muscle fibers, play a role in its onset and progression. Here, we will review the recent literature regarding the mechanisms leading to neuromuscular junction disassembly and muscle denervation focusing on the role of the three players of this peripheral tripartite synapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, neuromuscular junction dismantling and denervation occur in aged muscle, which are also key factors contributing to the onset of clinical symptoms and pathogenesis of ALS.293”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [293]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“In 1993, a landmark discovery of 11 missense mutations in the SOD1 gene, in 13 fALS families [47], heralded the genetic age for ALS.”
BackgroundProtein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454
Tripartite synapses: glia, the unacknowledged partner
Araque, A., Parpura, V., Sanzgiri, R. P., & Haydon, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01349-6 · Cited by 2,529 · cited 1×
“It was shown that they were able to respond to neuronal activity by increasing their intracellular Ca2+ concentration [1] and releasing chemical gliotransmitters (i.”
BackgroundOnset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623 · cited 1×
“The pathogenic role of mutant SOD1 expression in microglia has been equally investigated and, also in this case, it was show that by downregulating SOD1 levels in microglial cells in vivo increased the mean survival of the mutant mice by slowing disease progression after onset [101,102].”
BackgroundState of play in amyotrophic lateral sclerosis genetics
Renton, A. E., Chiò, A., & Traynor, B. J. (2014) · Nature Neuroscience · doi:10.1038/nn.3584 · Cited by 1,544 · cited 1×
“The progressive failure of the neuromuscular system results in weakness and atrophy of the limb musculature, gradual paralysis, and death from respiratory failure typically within two to three years of symptom onset [34].”
BackgroundAmyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man
Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A., Wang, M., Castellano-Sanchez, A., Khan, J., Polak, M. A., & Glass, J. D. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.10.004 · Cited by 1,357 · cited 1×
“, through glutamate excitotoxicity or altered neuronal excitability) and then extend in an anterograde fashion to corticospinal projections [61], or if ALS has to be considered a distal axonopathy in which motor neuron degeneration starts at the nerve endings and progress toward the cell bodies in a dying back manner…”
BackgroundGliotransmitters Travel in Time and Space
Araque, A., Carmignoto, G., Haydon, P. G., Oliet, S. H. R., Robitaille, R., & Volterra, A. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.007 · Cited by 1,308
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., Takahashi, R., Misawa, H., & Cleveland, D. W. (2008) · Nature Neuroscience · doi:10.1038/nn2047 · Cited by 1,140 · cited 1×
“On the other hand, it was shown that these cells played a relevant role in modulating ALS progression, since delayed microglial activation and slowed disease progression in SOD1 mice were observed [97,98] by reducing their level of expression of mutant SOD1.”
BackgroundWild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W., Siwek, D., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,100 · cited 1×
“This observation was confirmed by the generation of chimeric mice where it was shown that, in the absence of mutant SOD1 expression in non-neuronal cells, mutant SOD1 in neurons was not toxic in itself [67].”
BackgroundNon–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008 · cited 1×
“Moreover, in the past fifteen years, this was shown by expressing ALS-linked mutant proteins in a tissue or in a cell-specific manner [64].”
BackgroundThe epidemiology of ALS: a conspiracy of genes, environment and time
Al-Chalabi, A., & Hardiman, O. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.203 · Cited by 894 · cited 1×
“Possibly viral infections [41,42], autoimmune phenomena [43,44], and several other acquired causes linked to environmental conditions [45,46] could also contribute to the disease onset.”
BackgroundPun, S., Santos, A. F., Saxena, S., Xu, L., & Caroni, P. (2006) · Nature Neuroscience · doi:10.1038/nn1653 · Cited by 658 · cited 1×
“The reduction in the size of the synaptic vesicles pool was previously reported based on immunofluorescence experiments in NMJs of mutant SOD1 mice, and it was considered as a consequence of impaired vesicle transport in the axons of fast fatigable motor neurons [71].”
BackgroundThrombocytopenia in c-mpl-deficient mice
Gurney, A., Carver-Moore, K., de Sauvage, F., & Moore, M. (1994) · Science · doi:10.1126/science.8073287 · Cited by 652 · cited 1×
“Forced expression in mice of a human-mutated form of SOD1 (the mutant SOD1 G93A) resulted in the generation of transgenic mice [49] that recapitulates the pathogenic phenotype of ALS patients, namely, an adult onset neurodegenerative disease that is characterized by locomotor impairments, spinal cord and muscular atro…”
BackgroundVEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
Azzouz, M., Ralph, G. S., Storkebaum, E., Walmsley, L. E., Mitrophanous, K. A., Kingsman, S. M., Carmeliet, P., & Mazarakis, N. D. (2004) · Nature · doi:10.1038/nature02544 · Cited by 590 · cited 1×
“In support of the idea of a cross talk between motor axon terminals and muscle fibers, it was also shown that overexpression of Vascular endothelial growth factor (VEGF) and GDNF restricted to the skeletal muscle of SOD1 G93A significantly delayed the onset of the disease and increased mouse survival [85,86].”
BackgroundCongenital myasthenic syndromes: pathogenesis, diagnosis, and treatment
Engel, A. G., Shen, X.-M., Selcen, D., & Sine, S. M. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70201-7 · Cited by 553
Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse
Lin, W., Burgess, R. W., Dominguez, B., Pfaff, S. L., Sanes, J. R., & Lee, K.-F. (2001) · Nature · doi:10.1038/35074025 · Cited by 535 · cited 1×
“Subsequently it was shown (both in vitro and in vivo) [5–9] that clusters of acetylcholine receptors (AChRs) could form even in the absence of incoming motor axons and their signaling [6,9], leading to a different hypothesis (known as myocentric) of NMJ formation as a muscle-initiated event.”
BackgroundAmyotrophic lateral sclerosis—a model of corticofugal axonal spread
Braak, H., Brettschneider, J., Ludolph, A. C., Lee, V. M., Trojanowski, J. Q., & Tredici, K. D. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.221 · Cited by 527 · cited 1×
“, through glutamate excitotoxicity or altered neuronal excitability) and then extend in an anterograde fashion to corticospinal projections [61], or if ALS has to be considered a distal axonopathy in which motor neuron degeneration starts at the nerve endings and progress toward the cell bodies in a dying back manner…”
BackgroundTo build a synapse: signaling pathways in neuromuscular junction assembly
Wu, H., Xiong, W. C., & Mei, L. (2010) · Development · doi:10.1242/dev.038711 · Cited by 519 · cited 2×
“Which is the first event in the formation of the NMJ has long been considered as a chicken-and-egg problem [4]; which factors and pathways are initially involved in the formation of such synapse during embryonic development (in rodents, between embryonic day 12 and 13.”
BackgroundValdez, G., Tapia, J. C., Kang, H., Clemenson, G. D., Gage, F. H., Lichtman, J. W., & Sanes, J. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002220107 · Cited by 500 · cited 2×
“the is reminiscent of the poly-neuronal innervation of immature developing NMJ [19].”
BackgroundTransgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS
TURNER, B., & TALBOT, K. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.001 · Cited by 496 · cited 1×
“Rodents [50], zebrafish [51], but also the fruit fly [52–54] and the nematode worm [55–57], expressing ALS-linked mutated proteins have been used to study the neurobiological basis of ALS.”
BackgroundPramatarova, A., Laganière, J., Roussel, J., Brisebois, K., & Rouleau, G. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03369.2001 · Cited by 482 · cited 1×
“Initial studies on mice showed that neuron-specific mutant SOD1 expression was not sufficient for the development of the disease [65,66].”
BackgroundPatterning of Muscle Acetylcholine Receptor Gene Expression in the Absence of Motor Innervation
Yang, X., Arber, S., William, C., Li, L., Tanabe, Y., Jessell, T. M., Birchmeier, C., & Burden, S. J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00287-2 · Cited by 480 · cited 1×
“Subsequently it was shown (both in vitro and in vivo) [5–9] that clusters of acetylcholine receptors (AChRs) could form even in the absence of incoming motor axons and their signaling [6,9], leading to a different hypothesis (known as myocentric) of NMJ formation as a muscle-initiated event.”
BackgroundLino, M. M., Schneider, C., & Caroni, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04825.2002 · Cited by 424 · cited 1×
“Initial studies on mice showed that neuron-specific mutant SOD1 expression was not sufficient for the development of the disease [65,66].”
BackgroundMechanisms Regulating Neuromuscular Junction Development and Function and Causes of Muscle Wasting
Tintignac, L. A., Brenner, H.-R., & Rüegg, M. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00033.2014 · Cited by 422 · cited 4×
“Indeed, in NMJs from aged patients TSC processes were seen to invade the primary synaptic cleft [16].”
BackgroundInfluentialGong, Y. H., Parsadanian, A. S., Andreeva, A., Snider, W. D., & Elliott, J. L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00660.2000 · Cited by 369 · cited 1×
“In the CNS of animal models expressing mutant SOD1, the role of astrocytes has been extensively investigated and it was found that, whereas restricted expression of mutant SOD1 in astrocytes was able to induce astrogliosis, it did not cause motor neuron degeneration [96].”
BackgroundThe Neuromuscular Junction: Aging at the Crossroad between Nerves and Muscle
Gonzalez-Freire, M., de Cabo, R., Studenski, S. A., & Ferrucci, L. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00208 · Cited by 356
Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model
Dobrowolny, G., Giacinti, C., Pelosi, L., Nicoletti, C., Winn, N., Barberi, L., Molinaro, M., Rosenthal, N., & Musarò, A. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200407021 · Cited by 354 · cited 4×
“Another factor that causes a reduction in the level and efficacy of circulating IGF-1 is inflammation and it is known that aging is accompanied by a chronic mild inflammatory state sustained by increased levels of inflammatory cytokines, like interleukin 6 (IL-6), interleukin 1 (IL-1), tumor necrosis factor α (TNFα),…”
BackgroundInfluentialThe epidemiology of amyotrophic lateral sclerosis
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802973-2.00013-6 · Cited by 353 · cited 1×
“Possibly viral infections [41,42], autoimmune phenomena [43,44], and several other acquired causes linked to environmental conditions [45,46] could also contribute to the disease onset.”
BackgroundWong, M., & Martin, L. J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq106 · Cited by 314 · cited 2×
“It has been shown that muscle-specific mSOD1 expression induces progressive muscle atrophy associated with significant reduction in muscle strength and alterations in the contractile apparatus [80,81].”
BackgroundYamanaka, K., Boillee, S., Roberts, E. A., Garcia, M. L., McAlonis-Downes, M., Mikse, O. R., Cleveland, D. W., & Goldstein, L. S. B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802556105 · Cited by 309 · cited 1×
“On the other hand, it was shown that these cells played a relevant role in modulating ALS progression, since delayed microglial activation and slowed disease progression in SOD1 mice were observed [97,98] by reducing their level of expression of mutant SOD1.”
BackgroundMoloney, E. B., de Winter, F., & Verhaagen, J. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00252 · Cited by 307 · cited 1×
“, through glutamate excitotoxicity or altered neuronal excitability) and then extend in an anterograde fashion to corticospinal projections [61], or if ALS has to be considered a distal axonopathy in which motor neuron degeneration starts at the nerve endings and progress toward the cell bodies in a dying back manner…”
BackgroundIbebunjo, C., Chick, J. M., Kendall, T., Eash, J. K., Li, C., Zhang, Y., Vickers, C., Wu, Z., Clarke, B. A., Shi, J., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01036-12 · Cited by 267
Genetics of Amyotrophic Lateral Sclerosis
Ghasemi, M., & Brown, R. H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024125 · Cited by 262
Glial cells in amyotrophic lateral sclerosis
Philips, T., & Rothstein, J. D. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.05.015 · Cited by 250
Jaarsma, D., Teuling, E., Haasdijk, E. D., De Zeeuw, C. I., & Hoogenraad, C. C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5258-07.2008 · Cited by 247 · cited 1×
“On the other hand, a few years later it was reported that limited expression of mutant SOD1 in neurons was sufficient to induce an ALS phenotype in mice [68].”
BackgroundDenervation Causes Fiber Atrophy and Myosin Heavy Chain Co-Expression in Senescent Skeletal Muscle
Rowan, S. L., Rygiel, K., Purves-Smith, F. M., Solbak, N. M., Turnbull, D. M., & Hepple, R. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029082 · Cited by 246 · cited 1×
“Similarly, aging is associated with a reduction in the number of motor neurons in the spinal cord [18].”
BackgroundRobitaille, R. (1998) · Neuron · doi:10.1016/s0896-6273(00)80600-5 · Cited by 239 · cited 1×
“Even if the concept of tripartite synapse was initially developed for glutamatergic synapses in the central nervous system (CNS), early studies demonstrated that terminal Schwann cells (TSCs) (or perisynaptic Schwann cells) were equally able to modulate acetylcholine release at the frog neuromuscular junction (NMJ) [3…”
BackgroundZebrafish models of human motor neuron diseases: Advantages and limitations
Babin, P. J., Goizet, C., & Raldúa, D. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.03.001 · Cited by 227 · cited 1×
“Rodents [50], zebrafish [51], but also the fruit fly [52–54] and the nematode worm [55–57], expressing ALS-linked mutated proteins have been used to study the neurobiological basis of ALS.”
BackgroundAdvances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies
Vucic, S., Rothstein, J. D., & Kiernan, M. C. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.05.006 · Cited by 225 · cited 1×
“To date, 166 SOD1 mutations have been reported, accounting for 14–23% familial and 1–7% sporadic ALS cases [48].”
BackgroundWang, J., Farr, G. W., Hall, D. H., Li, F., Furtak, K., Dreier, L., & Horwich, A. L. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000350 · Cited by 206
The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis
Loeffler, J., Picchiarelli, G., Dupuis, L., & Gonzalez De Aguilar, J. (2016) · Brain Pathology · doi:10.1111/bpa.12350 · Cited by 206 · cited 2×
“As in neurons, the mitochondrial pool is one of the main intracellular targets of SOD1-mediated toxicity in the muscle fiber; thus, structural and functional defects were reported in muscle from sALS patients and transgenic mouse models [60,76], as well as defects in mitochondrial dynamics that can be observed either…”
BackgroundRemodeling of the neuromuscular junction precedes sarcopenia related alterations in myofibers
Deschenes, M. R., Roby, M. A., Eason, M. K., & Harris, M. B. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.03.007 · Cited by 191
Takahashi, Y., Fukuda, Y., Yoshimura, J., Toyoda, A., Kurppa, K. J., Moritoyo, H., Belzil, V., Dion, P. A., Higasa, K., Doi, K., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.09.008 · Cited by 190 · cited 1×
“Disruption of the neuregulin-ErbB4 pathway, induced by the loss of function mutation in the ErbB4 gene, was equally involved in the pathogenesis of ALS [116].”
BackgroundThe Role of MuSK in Synapse Formation and Neuromuscular Disease
Burden, S. J., Yumoto, N., & Zhang, W. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009167 · Cited by 190 · cited 2×
“These cues are represented by the patterned and restricted expression, on the muscle fiber plasma membrane, of MuSK and Lrp4 (low-density lipoprotein receptor-related protein 4), the agrin co-receptor, and by the agrin-independent activation of MuSK [10] (Figure 1).”
BackgroundNeuromuscular synaptogenesis: coordinating partners with multiple functions
Darabid, H., Perez-Gonzalez, A. P., & Robitaille, R. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3821 · Cited by 186 · cited 1×
“, agrin, WNT ligands, neuregulin 1, Glial cell-derived neurotrophic factor (GDNF), and Transforming growth factor (TGF)β) that can influence NMJ assembly and pre- and postsynaptic maturation and, on their turn, TSCs maturation is modulated by pre- and postsynaptically released factors (neuregulin 1, ATP, and laminins)…”
BackgroundMotor Axon Regeneration and Muscle Reinnervation in Young Adult and Aged Animals
Kang, H., & Lichtman, J. W. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4067-13.2013 · Cited by 186 · cited 1×
“toxicity and mitochondrial alterations in neurons [108], these data suggest that debris phagocytosis by TSCs in ALS might be impaired affecting efficient reinnervation processes [109].”
BackgroundLobsiger, C. S., Boillee, S., McAlonis-Downes, M., Khan, A. M., Feltri, M. L., Yamanaka, K., & Cleveland, D. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813339106 · Cited by 184 · cited 1×
“Strikingly, by reducing the expression of a dismutase active mutant SOD1 in myelinating Schwann cells, the progression of the disease is accelerated [106].”
BackgroundLoss of adult skeletal muscle stem cells drives age-related neuromuscular junction degeneration
Liu, W., Klose, A., Forman, S., Paris, N. D., Wei-LaPierre, L., Cortés-Lopéz, M., Tan, A., Flaherty, M., Miura, P., Dirksen, R. T., et al. (2017) · eLife · doi:10.7554/elife.26464 · Cited by 181 · cited 1×
“Elderly people and ALS patients share common features, starting from reduction in muscle mass and strength, altered metabolism of muscle fibers, which correlates not only with aging, but also with reduced physical exercise, reduced circulating levels of trophic factors, defects in retrograde transport from the nerve e…”
BackgroundDa Cruz, S., Parone, P. A., Lopes, V. S., Lillo, C., McAlonis-Downes, M., Lee, S. K., Vetto, A. P., Petrosyan, S., Marsala, M., Murphy, A. N., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.019 · Cited by 177 · cited 1×
“Boosting mitochondrial biogenesis with the overexpression of PGC-1α can restore mitochondrial and muscle functions in SOD1G37R mice without, however, improving mouse survival [79].”
BackgroundMicroglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175 · cited 1×
“Possibly viral infections [41,42], autoimmune phenomena [43,44], and several other acquired causes linked to environmental conditions [45,46] could also contribute to the disease onset.”
BackgroundRocha, M. C., Pousinha, P. A., Correia, A. M., Sebastião, A. M., & Ribeiro, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073846 · Cited by 165 · cited 1×
“Whereas neuromuscular transmission of mutant SOD1 mice was enhanced in the pre-symptomatic phase, it becomes impaired in a subset of NMJs at later stages of the disease [88].”
BackgroundThe ageing neuromuscular system and sarcopenia: A mitochondrial perspective
Rygiel, K. A., Picard, M., & Turnbull, D. M. (2016) · The Journal of Physiology · doi:10.1113/jp271212 · Cited by 165 · cited 2×
“However, it is still a matter of debate whether this reduction is due to decreased levels of the peroxisome proliferator-activated receptor γ co-activator 1α (PGC-1α) (known as a master regulator of mitochondrial biogenesis) in aging muscles [26].”
BackgroundThe Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
Blasco, H., Mavel, S., Corcia, P., & Gordon, P. H. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140916120118 · Cited by 164 · cited 1×
“ALS is known to be a complex disease with a multifactorial pathogenesis in which several factors could increase the susceptibility to the disease [36], among those include glutamate-mediated excitotoxicity [37], oxidative stress [38], mitochondrial pool alteration [39] and dysfunction [35], and abnormal protein aggreg…”
BackgroundA Drosophila Model for Amyotrophic Lateral Sclerosis Reveals Motor Neuron Damage by Human SOD1
Watson, M. R., Lagow, R. D., Xu, K., Zhang, B., & Bonini, N. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804817200 · Cited by 163
Aging and muscle: a neuronʼs perspective
Manini, T. M., Hong, S. L., & Clark, B. C. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32835b5880 · Cited by 159
Development of the neuromuscular junction
Witzemann, V. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0237-x · Cited by 157
Liu, W., Wei-LaPierre, L., Klose, A., Dirksen, R. T., & Chakkalakal, J. V. (2015) · eLife · doi:10.7554/elife.09221 · Cited by 151 · cited 1×
“Elderly people and ALS patients share common features, starting from reduction in muscle mass and strength, altered metabolism of muscle fibers, which correlates not only with aging, but also with reduced physical exercise, reduced circulating levels of trophic factors, defects in retrograde transport from the nerve e…”
BackgroundPollari, E., Goldsteins, G., Bart, G., Koistinaho, J., & Giniatullin, R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00131 · Cited by 150 · cited 1×
“species (ROS) accumulation and this suggests that oxidative stress, along with altered mitochondria and increased intracellular Ca2+ levels, accelerates the presynaptic decline in NMJ and affects the neurotransmitter release machinery in the presynaptic terminals [70].”
BackgroundSynergy of insulin‐like growth factor‐1 and exercise in amyotrophic lateral sclerosis
Kaspar, B. K., Frost, L. M., Christian, L., Umapathi, P., & Gage, F. H. (2005) · Annals of Neurology · doi:10.1002/ana.20451 · Cited by 147 · cited 1×
“On the contrary, muscle hypertrophy induced by localized expression of insulin-like growth factor-1 (IGF-1) [83] or growth hormone has been shown to exert beneficial effects on fALS mouse survival, especially when associated with moderate physical exercise [80,84].”
BackgroundSinghal, N., & Martin, P. T. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20953 · Cited by 140 · cited 1×
“, laminins) that will compose the synaptic basal lamina, a structure that, in time, has been demonstrated to play a pivotal role in different aspects of NMJ development, such as synaptic initiation, maturation, and stability, but also in maintaining its structural integrity [11].”
BackgroundBütikofer, L., Zurlinden, A., Bolliger, M. F., Kunz, B., & Sonderegger, P. (2011) · The FASEB Journal · doi:10.1096/fj.11-191262 · Cited by 138 · cited 1×
“Further evidence about the involvement of the Agrin/MuSK/Lrp4 pathway in age-related changes at the NMJ and the reduction in muscle mass come from the observation that, by overexpressing neurotrypsin, the neural serin-protease that is responsible for the inactivating cleavage of agrin, not only are NMJs dismantled in…”
BackgroundKang, H., Tian, L., Mikesh, M., Lichtman, J. W., & Thompson, W. J. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4673-13.2014 · Cited by 137 · cited 1×
“Activated TSCs are equally important for the guidance of axonal sprouting to reinnervate the previously-occupied synaptic clefts, to remodel the post-synaptic clusters of AChRs, and to stabilize newly-reinnervated NMJs [110].”
BackgroundMitochondrial dysfunction in amyotrophic lateral sclerosis – a valid pharmacological target?
Muyderman, H., & Chen, T. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12476 · Cited by 134 · cited 1×
“toxicity and mitochondrial alterations in neurons [108], these data suggest that debris phagocytosis by TSCs in ALS might be impaired affecting efficient reinnervation processes [109].”
BackgroundInteraction Between Bone and Muscle in Older Persons with Mobility Limitations
Ferrucci, L., Baroni, M., Ranchelli, A., Lauretani, F., Maggio, M., Mecocci, P., & Ruggiero, C. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660690 · Cited by 131
Xia, R., Liu, Y., Yang, L., Gál, J., Zhu, H., & Jia, J. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-10 · Cited by 129 · cited 1×
“Indeed, functional and imaging studies have shown that presynaptic motor nerve terminals’ formation and maturation was impaired at the larval muscle NMJ in drosophila models of FUS-mediated ALS [72] and that substantial presynaptic defects were observed at the NMJ in drosophila larvae expressing mutant VAP-B [73].”
BackgroundLi, W., Brakefield, D., Pan, Y., Hunter, D., Myckatyn, T. M., & Parsadanian, A. S. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.028 · Cited by 126 · cited 1×
“In support of the idea of a cross talk between motor axon terminals and muscle fibers, it was also shown that overexpression of Vascular endothelial growth factor (VEGF) and GDNF restricted to the skeletal muscle of SOD1 G93A significantly delayed the onset of the disease and increased mouse survival [85,86].”
BackgroundOeda, T. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.19.2013 · Cited by 124
Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo
Qian, K., Huang, H., Peterson, A., Hu, B., Maragakis, N. J., Ming, G.-L., Chen, H., & Zhang, S.-C. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.03.003 · Cited by 123 · cited 1×
“In support of an active role of astrocytes in promoting motor neuron degeneration in ALS, recent data demonstrated that not only astrocytes expressing ALS-associated proteins [99], but also astrocytes from sALS patients, are capable of inducing motor neuron degeneration in vivo [100].”
BackgroundLuo, G., Yi, J., Ma, C., Xiao, Y., Yi, F., Yu, T., & Zhou, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082112 · Cited by 114 · cited 1×
“As in neurons, the mitochondrial pool is one of the main intracellular targets of SOD1-mediated toxicity in the muscle fiber; thus, structural and functional defects were reported in muscle from sALS patients and transgenic mouse models [60,76], as well as defects in mitochondrial dynamics that can be observed either…”
BackgroundClark, J. A., Southam, K. A., Blizzard, C. A., King, A. E., & Dickson, T. C. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.03.003 · Cited by 111 · cited 2×
“Consistent with the dying-back hypothesis in ALS pathogenesis, it was found that distal axonal and NMJ alterations were present in muscles of SOD1 G93A mice before the onset of the clinical symptoms [69].”
BackgroundPerisynaptic Schwann Cells at the Neuromuscular Synapse: Adaptable, Multitasking Glial Cells
Ko, C.-P., & Robitaille, R. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020503 · Cited by 109 · cited 2×
“Even if it is now acknowledged that Schwann cells are not necessary for the establishment of the first contact between nerve and muscle [12], recent studies on the development”
BackgroundSchwann Cells in Neuromuscular Junction Formation and Maintenance
Barik, A., Li, L., Sathyamurthy, A., Xiong, W.-C., & Mei, L. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0174-16.2016 · Cited by 109 · cited 1×
“Recent studies based on Schwann cell ablation during embryonic and early postnatal life in mice, suggest that during these later phases of NMJ development, TSCs specifically modulate AChRs maturation, and that they are equally important for NMJ stability in adult life [14].”
BackgroundEarly and Persistent Abnormal Decoding by Glial Cells at the Neuromuscular Junction in an ALS Model
Arbour, D., Tremblay, E., Martineau, É., Julien, J., & Robitaille, R. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1379-14.2015 · Cited by 106 · cited 3×
“In support of this hypothesis is evidence of hyper-muscarinic activity of TSCs in mutant SOD1 mice at disease onset [111].”
BackgroundALS syndrome in patients with HIV-1 infection
Verma, A. K., & Berger, J. R. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.09.005 · Cited by 105 · cited 1×
“Possibly viral infections [41,42], autoimmune phenomena [43,44], and several other acquired causes linked to environmental conditions [45,46] could also contribute to the disease onset.”
BackgroundMarcuzzo, S., Zucca, I., Mastropietro, A., de Rosbo, N. K., Cavalcante, P., Tartari, S., Bonanno, S., Preite, L., Mantegazza, R., & Bernasconi, P. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.05.007 · Cited by 103 · cited 1×
“Similarly, it was shown that defects in muscle metabolism and the reduction in muscle mass can be observed in the SOD1 G93A mice before any evidence of central neuron degeneration [82].”
BackgroundFailed reinnervation in aging skeletal muscle
Aare, S., Spendiff, S., Vuda, M., Elkrief, D., Perez, A., Wu, Q., Mayaki, D., Hussain, S. N. A., Hettwer, S., & Hepple, R. T. (2016) · Skeletal Muscle · doi:10.1186/s13395-016-0101-y · Cited by 102 · cited 1×
“Recent data showed that genes coding for different subunits of the AChR (α, δ, γ), as well as MuSK and Lrp4, were significantly up-regulated in aged rats [21,22].”
BackgroundThe multifaceted role of glial cells in amyotrophic lateral sclerosis
Valori, C. F., Brambilla, L., Martorana, F., & Rossi, D. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1429-7 · Cited by 100 · cited 1×
“The pathogenic role of mutant SOD1 expression in microglia has been equally investigated and, also in this case, it was show that by downregulating SOD1 levels in microglial cells in vivo increased the mean survival of the mutant mice by slowing disease progression after onset [101,102].”
BackgroundKawamata, H., Ng, S. K., Diaz, N., Burstein, S., Morel, L., Osgood, A., Sider, B., Higashimori, H., Haydon, P. G., Manfredi, G., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2689-13.2014 · Cited by 97 · cited 4×
“In the CNS of animal models expressing mutant SOD1, the role of astrocytes has been extensively investigated and it was found that, whereas restricted expression of mutant SOD1 in astrocytes was able to induce astrogliosis, it did not cause motor neuron degeneration [96].”
BackgroundInfluentialKeller, A. F., Gravel, M., & Kriz, J. (2009) · Glia · doi:10.1002/glia.20836 · Cited by 96 · cited 2×
“Interestingly VEGF exerted its function in part by counteracting astrogliosis in the CNS and by preventing NMJs’ denervation in the PNS [87].”
BackgroundChai, A., Withers, J., Koh, Y. H., Parry, K., Bao, H., Zhang, B., Budnik, V., & Pennetta, G. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm303 · Cited by 94
Amyotrophic Lateral Sclerosis and Skeletal Muscle: An Update
Pansarasa, O., Rossi, D., Berardinelli, A. L., & Cereda, C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8578-4 · Cited by 86 · cited 2×
“Defects of mitochondrial activity in muscles are accompanied by mutant SOD1 cytosolic aggregates formation which, in muscle, are mostly removed by both proteasome- and autophagy-mediated degradation [76] and an increased amount of reactive oxygen species.”
BackgroundDuregotti, E., Negro, S., Scorzeto, M., Zornetta, I., Dickinson, B. C., Chang, C. J., Montecucco, C., & Rigoni, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417108112 · Cited by 82 · cited 1×
“TSCs then acquire a macrophage-like behavior and phagocyte axonal and cellular debris; this process is triggered by mitochondrial factors (alarmins) [107] that are released by degenerating axons, and is relevant to promote and facilitate re-innervation.”
BackgroundSugita, S., Fleming, L. L., Wood, C., Doss, S. V., Gomes, M. P. S. M., de Camargo, W. L., Naves, L. A., Prado, V. F., Prado, M. A. M., Guatimosim, C., et al. (2016) · Skeletal Muscle · doi:10.1186/s13395-016-0105-7 · Cited by 76
Arbour, D., Vande Velde, C., & Robitaille, R. (2017) · The Journal of Physiology · doi:10.1113/jp270213 · Cited by 75
Human-derived neural progenitors functionally replace astrocytes in adult mice
Chen, H., Qian, K., Chen, W., Hu, B., Blackbourn, L. W., Du, Z., Ma, L., Liu, H., Knobel, K. M., Ayala, M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci69097 · Cited by 71 · cited 1×
“In support of an active role of astrocytes in promoting motor neuron degeneration in ALS, recent data demonstrated that not only astrocytes expressing ALS-associated proteins [99], but also astrocytes from sALS patients, are capable of inducing motor neuron degeneration in vivo [100].”
BackgroundAcetylcholine receptors from human muscle as pharmacological targets for ALS therapy
Palma, E., Reyes-Ruiz, J. M., Lopergolo, D., Roseti, C., Bertollini, C., Ruffolo, G., Cifelli, P., Onesti, E., Limatola, C., Miledi, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600251113 · Cited by 70 · cited 1×
“These observations support the hypothesis that ALS-mediated denervation of skeletal muscle induces changes at the NMJ that are not shared by denervated muscles after a trauma or because of other neuromuscular pathologies [90,91].”
ResultTurner, B. J., Ackerley, S., Davies, K. E., & Talbot, K. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp550 · Cited by 69 · cited 1×
“These animals were indistinguishable from wild type littermates, suggesting that expression of mutant SOD1 in myelinating Schwann cells had no effect on motor neurons and was not linked to ALS pathogenesis [105].”
BackgroundCampanari, M.-L., García-Ayllón, M.-S., Ciura, S., Sáez-Valero, J., & Kabashi, E. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00160 · Cited by 69
VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice
Zheng, C., Sköld, M. K., Li, J., Nennesmo, I., Fadeel, B., & Henter, J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.088 · Cited by 68 · cited 2×
“Later studies in mutant SOD1 mice expressing luciferase under the control of the Glial Fibrillar Acidic Protein (GFAP) promoter showed that, while in the spinal cord, astrocyte activation occurred at presymptomatic stages of the disease, the appearance of the clinical symptoms corresponded with the activation of GFAP…”
BackgroundTaetzsch, T., Tenga, M. J., & Valdez, G. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2992-16.2016 · Cited by 68 · cited 2×
“Increasing levels of TGF-β1 in muscle fibers, and specifically at the NMJs, might be at the basis of FGFBP1 decrease [25].”
BackgroundLasiene, J., Komine, O., Fujimori-Tonou, N., Powers, B. E., Endo, F., Watanabe, S., Jin, S., Ravits, J., Horner, P. J., Misawa, H., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0286-7 · Cited by 62 · cited 1×
“NRG expression is reduced in the spinal cord of ALS patients and mice models and viral mediated delivery on NRG1 in mice could extend mice survival [115].”
BackgroundPietro, L. D., Baranzini, M., Berardinelli, M. G., Lattanzi, W., Monforte, M., Tasca, G. A., Conte, A., Logroscino, G., Michetti, F., Ricci, E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10161-z · Cited by 58 · cited 1×
“Recent studies on microRNA content in muscle from sporadic and familial ALS patients identified molecular pathways that could affect re-innervation and muscle fiber regeneration which, subsequently, could have an impact in maintaining neuromuscular junction stability in ALS [95].”
BackgroundMitochondria, motor neurons and aging
García, M. L., Fernández, A., & Solas, M. T. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.03.019 · Cited by 54 · cited 1×
“Moreover in the cytoplasm of the axon terminals activated caspase 3 and cytochrome C (triggers of the mitochondrial-dependent pathway to apoptosis) were detected, pointing to the nerve ending as the primary site of motor neuron degeneration in aging [27].”
BackgroundDobrowolny, G., Aucello, M., Molinaro, M., & Musarò, A. (2008) · Neurological Research · doi:10.1179/174313208x281235 · Cited by 54 · cited 3×
“It has been shown that muscle-specific mSOD1 expression induces progressive muscle atrophy associated with significant reduction in muscle strength and alterations in the contractile apparatus [80,81].”
BackgroundBahadorani, S., Mukai, S. T., Rabie, J., Beckman, J. S., Phillips, J. P., & Hilliker, A. J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.024 · Cited by 50
Benedetti, L., Ghilardi, A., Rottoli, E., Maglie, M. D., Prosperi, L., Perego, C., Baruscotti, M., Bucchi, A., Giacco, L. D., & Francolini, M. (2016) · Scientific Reports · doi:10.1038/srep24515 · Cited by 49
Self-citationALS and Oxidative Stress: The Neurovascular Scenario
Anand, A., Thakur, K., & Gupta, P. K. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/635831 · Cited by 47 · cited 1×
“ALS is known to be a complex disease with a multifactorial pathogenesis in which several factors could increase the susceptibility to the disease [36], among those include glutamate-mediated excitotoxicity [37], oxidative stress [38], mitochondrial pool alteration [39] and dysfunction [35], and abnormal protein aggreg…”
BackgroundAltered terminal Schwann cell morphology precedes denervation in SOD1 mice
Carrasco, D. I., Seburn, K. L., & Pinter, M. J. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.09.014 · Cited by 46 · cited 1×
“Recent data from mutant SOD1 mice have shown that TSCs undergo morphological alteration and reduction in their number before NMJ denervation [113], and many of them further react to denervation by activating their apoptotic pathways instead of promoting reinnervation [114], thus, any motor neuron sprouting from nearby…”
BackgroundLømo, T. (2003) · Journal of Neurocytology · doi:10.1023/b:neur.0000020627.18156.b1 · Cited by 46
Cappello, V., Vezzoli, E., Righi, M., Fossati, M., Mariotti, R., Crespi, A., Patruno, M., Bentivoglio, M., Pietrini, G., & Francolini, M. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.07.003 · Cited by 44 · cited 2×
“Synaptic vesicle density in motor axon terminals from mutant SOD1 mice was significantly reduced compared to wild-type ones [39].”
BackgroundSelf-citationQuantitative Axon Terminal and End-plate Morphology in Amyotrophic Lateral Sclerosis
Bjornskov, E. K., Norris, F. H., & Mower‐Kuby, J. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050170073021 · Cited by 44 · cited 1×
“Early studies on muscles from ALS patients showed that the amount and distribution of acetylcholine receptors, as well as the postsynaptic architecture of the NMJ were not significantly altered even in fully-denervated endplates [92,93].”
BackgroundPhysiological characterization of human muscle acetylcholine receptors from ALS patients
Palma, E., Inghilleri, M., Conti, L., Deflorio, C., Frasca, V., Manteca, A., Pichiorri, F., Roseti, C., Torchia, G., Limatola, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117975108 · Cited by 43 · cited 1×
“These observations support the hypothesis that ALS-mediated denervation of skeletal muscle induces changes at the NMJ that are not shared by denervated muscles after a trauma or because of other neuromuscular pathologies [90,91].”
ResultTsujihata, M., Hazama, R., Yoshimura, T., Satoh, A., Mori, M., & Nagataki, S. (1984) · Muscle & Nerve · doi:10.1002/mus.880070310 · Cited by 41 · cited 1×
“Early studies on muscles from ALS patients showed that the amount and distribution of acetylcholine receptors, as well as the postsynaptic architecture of the NMJ were not significantly altered even in fully-denervated endplates [92,93].”
BackgroundActive zones of mammalian neuromuscular junctions: formation, density, and aging
Nishimune, H. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06836.x · Cited by 40 · cited 1×
“These data were consistent with the defects in synaptic functions that have been reported in time, namely reduced end-plate potential and stronger synaptic depression after repeated stimulation and reduced frequency of miniature end-plate potentials [20].”
ResultAmyotrophic lateral sclerosis: one or multiple causes?
Bastos, A. F., Orsini, M. A., Machado, D. D. C. D., de Mello, M. P., Nader, S., Silva, J. G., Catharino, A. M. D. S., Bastos, V. H., Pereira, A., Pessôa, L. L. D. O., et al. (2011) · Neurology International · doi:10.4081/ni.2011.e4 · Cited by 38 · cited 1×
“ALS is known to be a complex disease with a multifactorial pathogenesis in which several factors could increase the susceptibility to the disease [36], among those include glutamate-mediated excitotoxicity [37], oxidative stress [38], mitochondrial pool alteration [39] and dysfunction [35], and abnormal protein aggreg…”
BackgroundAnti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited
Kollewe, K., Wurster, U., Sinzenich, T., Körner, S., Dengler, R., Mohammadi, B., & Petri, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125339 · Cited by 35 · cited 1×
“Possibly viral infections [41,42], autoimmune phenomena [43,44], and several other acquired causes linked to environmental conditions [45,46] could also contribute to the disease onset.”
BackgroundSporadic amyotrophic lateral sclerosis: A hypothesis of persistent (non‐lytic) enteroviral infection
Ravits, J. (2005) · Amyotrophic Lateral Sclerosis · doi:10.1080/14660820510027026 · Cited by 34 · cited 1×
“Possibly viral infections [41,42], autoimmune phenomena [43,44], and several other acquired causes linked to environmental conditions [45,46] could also contribute to the disease onset.”
BackgroundA study of three patients with amyotrophic lateral sclerosis and a polyneuropathy resembling CIDP
Echaniz‐Laguna, A., Degos, B., Mohr, M., Kessler, R., Urban-Kraemer, E., & Tranchant, C. (2005) · Muscle & Nerve · doi:10.1002/mus.20475 · Cited by 34 · cited 1×
“As in neurons, the mitochondrial pool is one of the main intracellular targets of SOD1-mediated toxicity in the muscle fiber; thus, structural and functional defects were reported in muscle from sALS patients and transgenic mouse models [60,76], as well as defects in mitochondrial dynamics that can be observed either…”
BackgroundLi, J., Li, T., Zhang, X., Tang, Y., Yang, J., & Le, W. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.003 · Cited by 32
Aging and the Energetic Cost of Life
Ferrucci, L., Schrack, J. A., Knuth, N. D., & Simonsick, E. M. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04102.x · Cited by 31
Yoshihara, T., Ishii, T., Makoto, I., & Nomoto, M. (1998) · Ultrastructural Pathology · doi:10.3109/01913129809032266 · Cited by 26 · cited 1×
“In particular it was demonstrated that, whereas the postsynaptic primary gutter was occasionally flattened (possibly an effect mediated by the reduction in caliber of denervated fibers), secondary folds were always well preserved [94].”
BackgroundAbnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease
Carrasco, D. I., Bahr, B. A., Seburn, K. L., & Pinter, M. J. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.02.002 · Cited by 23 · cited 1×
“Recent data from mutant SOD1 mice have shown that TSCs undergo morphological alteration and reduction in their number before NMJ denervation [113], and many of them further react to denervation by activating their apoptotic pathways instead of promoting reinnervation [114], thus, any motor neuron sprouting from nearby…”
BackgroundIslam, R., Kumimoto, E. L., Bao, H., & Zhang, B. (2012) · F1000Research · doi:10.12688/f1000research.1-47.v1 · Cited by 20
Changes in the myelinated axons of femoral nerve in amyotrophic lateral sclerosis.
Perrie, W. T., Gt, L., Em, C., Sparke, J., Buller, & Ml, R. (1993) · PubMed · Cited by 17
Dzieciolowska, S., Drapeau, P., & Armstrong, G. A. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177005 · Cited by 17 · cited 1×
“Expression of mutant SOD1 and reduced expression of TDP-43 in Zebrafish embryos and larvae both resulted in abnormal motor neuron branching and defective formation of presynaptic nerve endings [74,75].”
BackgroundAn explant muscle model to examine the refinement of the synaptic landscape
Hanson, M. G., & Niswander, L. A. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.09.013 · Cited by 10
Cited by
Nimgampalle, M., Chakravarthy, H., Sharma, S., Shree, S., Bhat, A. R., Pradeepkiran, J. A., & Devanathan, V. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101994 · Cited by 207
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“293 In addition, a well-recognized observation in HD patients is defects in energy metabolism in skeletal muscle. mHTT affects mitochondrial complex activation and dysfunction of the mitochondrial respiratory chain in skeletal muscle, which may be markers of HD progression.”
3D bioprinting of complex tissues in vitro: state-of-the-art and future perspectives
Xiang, Y., Miller, K. L., Guan, J., Kiratitanaporn, W., Tang, M., & Chen, S. (2022) · Archives of Toxicology · doi:10.1007/s00204-021-03212-y · Cited by 105
“2014, Cappello and Francolini 2017).”
Decoding the relationship between ageing and amyotrophic lateral sclerosis: a cellular perspective
Pandya, V. A., & Patani, R. (2020) · Brain · doi:10.1093/brain/awz360 · Cited by 86
Tissue-Engineered Skeletal Muscle Models to Study Muscle Function, Plasticity, and Disease
Khodabukus, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.619710 · Cited by 97
“Importantly, the use of hiPSCs allows the modeling of multiple human neuromuscular disease such as MG, spinal muscular atrophy (SMA), and ALS which would not be possible due to the post-mitotic state of adult motor neurons (Dimos et al., 2008; Ebert et al., 2009; Sances et al., 2016).”
Background
Metadata
- Authors
- Cappello, V., & Francolini, M.
- Affiliations
- Italian Institute of Technology (IT)
- University of Milan (IT)
- Corresponding author
- Cappello, Valentina
- Francolini, Maura
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-10-03
- Volume
- 18
- Issue
- 10
- Pages
- 2092
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5666774
- OpenAlex
- W2761206394
- Cited by
- 119
- References
- 117
- Citations by year
- 2026: 13 · 2025: 11 · 2024: 19 · 2023: 14 · 2022: 18 · 2021: 17 · 2020: 8 · 2019: 13 · 2018: 6
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- amyotrophic lateral sclerosis, muscle denervation, motor neuron degeneration, glial cells, synaptic plasticity, skeletal muscle atrophy
- MeSH terms
- Aging, Amyotrophic Lateral Sclerosis, Animals, Humans, Motor Neurons, Neuroglia, Neuromuscular Junction, Schwann Cells, Synapses, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.